ClinicalTrials.Veeva

Menu

Hemorrhoid Radiofrequency (RFH)

F

Fondation Hôpital Saint-Joseph

Status

Enrolling

Conditions

Hemorrhoid Prolapse

Treatments

Procedure: radiofrequency

Study type

Observational

Funder types

Other

Identifiers

NCT06079892
647-AAM-RFH

Details and patient eligibility

About

Triapedicular haemorroidectomy is currently the gold standard in haemorrhoidal pathology. Minimally invasive surgical techniques now play an important role in the haemorrhoidal management algorithm, particularly for less advanced stages of the disease. Among these techniques, radiofrequency is one of the most recent and is gradually gaining ground. It involves applying a radiofrequency current to the internal haemorrhoidal tissue in order to induce its involution.

The literature has shown that this technique leads to symptomatic improvement in over 60% of cases and a high satisfaction rate, even though some patients still seem to have haemorrhoidal symptoms postoperatively.

The aim of this study is to evaluate the efficacy of this technique in patients with haemorrhoidal pathology operated on at our centre, using "hard" criteria which are thought to be more rigorous ("cure" rather than "improvement").

Enrollment

80 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥ 18 years
  • Presence of haemorrhoidal pathology
  • Patient operated on between March 2017 and March 2023, using the radiofrequency technique
  • French-speaking patient

Exclusion criteria

  • ano-perineal involvement in Crohn's disease
  • perianal fistula
  • non-quiescent IBD
  • radiation-induced rectitis
  • psychiatric pathology.
  • under guardianship or curatorship
  • deprived of liberty
  • under court protection
  • Patient objecting to the use of his/her data for this research

Trial contacts and locations

1

Loading...

Central trial contact

Amine Antonin Alam, MD; Hélène BEAUSSIER, PharmaD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems